Owner | Filings | Transaction Date | Type of Owner |
---|---|---|---|
Smith Susan Laura | 0001901039 | Dec-14-2021 | officer: Senior Vice President, CCO |
Hamill Laura | 0001751804 | Jun-11-2020 | director |
Rajah Vignesh | 0001815042 | Jun-02-2020 | officer: SVP and CMO |
Herman Philip Karl | 0001799303 | Jan-01-2020 | officer: Sr. VP and CCO |
Ahmed Mahiuddin | 0001799304 | Jan-01-2020 | officer: Sr. VP and CSO |
Raskin Gregory S | 0001753646 | Aug-29-2019 | director |
Ber Gerard | 0001762144 | Dec-11-2018 | director |
GILL DAVID N | 0001106519 | Sep-20-2018 | director |
HEALY JAMES | 0001245624 | Sep-20-2018 | director |
TYAGI ASHU | 0001752467 | Sep-20-2018 | director |
Kruse Bo | 0001752940 | Sep-20-2018 | director, officer: EVP, CFO, Secy & Treas. |
Lund-Hansen Torben | 0001753134 | Sep-20-2018 | officer: Sr. VP and Head of Tech Op |
Lisby Steen | 0001753152 | Sep-20-2018 | officer: Sr. VP and CMO |
Wedell-Wedellsborg Johan | 0001753185 | Sep-20-2018 | director, 10 percent owner |
WG Biotech ApS | 0001753193 | Sep-20-2018 | 10 percent owner |
Juan Moller San Pedro Claus | 0001753222 | Sep-20-2018 | director, officer: Chief Executive Officer |
Gad Thomas | 0001753224 | Sep-20-2018 | director, officer: President and Chairman |
Wilms Joris | 0001753231 | Sep-20-2018 | officer: Sr. VP and COO |
Buschle Michael | 0001753357 | Sep-20-2018 | director |
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Y-mAbs Therapeutics, Inc.
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-003743 ( Act) Size: 16 KB |
Feb-14-2024 | |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001104659-24-023631 (34 Act) Size: 54 KB |
Feb-14-2024 | 24638031 |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001104659-24-022348 (34 Act) Size: 12 KB |
Feb-13-2024 | 24629984 |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001104659-24-019879 (34 Act) Size: 36 KB |
Feb-13-2024 | 24625868 |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000902664-24-001099 (34 Act) Size: 97 KB |
Feb-06-2024 | 24600069 |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001086364-24-004907 (34 Act) Size: 13 KB |
Jan-26-2024 | 24569217 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-001650 ( Act) Size: 15 KB |
Jan-22-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-001649 ( Act) Size: 13 KB |
Jan-22-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-001648 ( Act) Size: 14 KB |
Jan-22-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-001647 ( Act) Size: 14 KB |
Jan-22-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-001646 ( Act) Size: 14 KB |
Jan-22-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-001645 ( Act) Size: 15 KB |
Jan-22-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-001644 ( Act) Size: 13 KB |
Jan-22-2024 | |
8-K | Document | Current report filing Acc-no: 0001104659-24-002442 (34 Act) Size: 11069 KB |
Jan-09-2024 | 24521691 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001104659-23-129202 ( Act) Size: 9 KB |
Dec-26-2023 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001104659-23-126508 ( Act) Size: 11 KB |
Dec-15-2023 | |
144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001968582-23-000768 (33 Act) Size: 5 KB |
Dec-13-2023 | 231484503 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001104659-23-125200 ( Act) Size: 5 KB |
Dec-12-2023 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001104659-23-125199 ( Act) Size: 5 KB |
Dec-12-2023 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001104659-23-125055 ( Act) Size: 9 KB |
Dec-11-2023 |
Recent 20 filings. View all Y-mAbs Therapeutics, Inc. filings
It's being easier working on the website. And I recommend, it's a great website
Very good communication and delivery made within the timeframe I was advised of
young lad who new his job ansered questions and new what was best for me.
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by